Medios AG Stock

Equities

ILM1

DE000A1MMCC8

Pharmaceuticals

Market Closed - Xetra 11:36:00 2024-07-05 am EDT 5-day change 1st Jan Change
16.08 EUR +0.50% Intraday chart for Medios AG -0.37% +1.39%
Sales 2024 * 2.01B 2.18B Sales 2025 * 2.17B 2.35B Capitalization 410M 445M
Net income 2024 * 28M 30.34M Net income 2025 * 44M 47.68M EV / Sales 2024 * 0.28 x
Net Debt 2024 * 157M 170M Net Debt 2025 * 110M 119M EV / Sales 2025 * 0.24 x
P/E ratio 2024 *
14 x
P/E ratio 2025 *
9.99 x
Employees 500
Yield 2024 *
-
Yield 2025 *
-
Free-Float 92.4%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.50%
1 week-0.37%
Current month-0.37%
1 month+8.21%
3 months+3.08%
6 months+5.65%
Current year+1.39%
More quotes
1 week
15.82
Extreme 15.82
16.38
1 month
15.58
Extreme 15.58
17.28
Current year
13.74
Extreme 13.74
18.00
1 year
13.34
Extreme 13.34
18.06
3 years
13.34
Extreme 13.34
41.60
5 years
13.34
Extreme 13.34
42.00
10 years
7.41
Extreme 7.41
42.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 14-11-05
Director of Finance/CFO 53 21-09-30
Chief Operating Officer 55 17-06-30
Members of the board TitleAgeSince
Chairman 51 14-11-06
Director/Board Member 62 16-09-13
Director/Board Member 63 16-09-13
More insiders
Date Price Change Volume
24-07-05 16.08 +0.50% 24,729
24-07-04 16 -0.62% 8,827
24-07-03 16.1 0.00% 25,366
24-07-02 16.1 -1.47% 32,838
24-07-01 16.34 +1.24% 13,302

Delayed Quote Xetra, July 05, 2024 at 11:36 am EDT

More quotes
Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
16.08 EUR
Average target price
32 EUR
Spread / Average Target
+99.00%
Consensus